Sputnik V, the Russian COVID vaccine has claimed that the available public data suggests more people died after taking the Pfizer vaccine than AstraZeneca.
COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.
‘Sputnik V study shows that there are significantly more deaths following vaccination with Pfizer than with AstraZeneca vaccine per 1 million administered doses, based on official publicly available data by 13 international health regulators.
’
Both Pfizer and AstraZeneca were yet to react to the Sputnik V study. In January, 23 elderly patients reportedly died in Norway following their immunization with the Pfizer-BioNTech mRNA vaccine against Covid-19.
On the other hand, several countries have halted the use of AstraZeneca as the shot may have caused some recipients to develop blood clots.
Sputnik V: Here's All You Need to Know About the Covid Jab
Sputnik V vaccine has been approved to tackle Covid-19 in 60 countries across the world. India is gonna import the vaccine and use it for emergencies. The efficacy of Sputnik V was determined to be 91.6% by The Lancet.
Sputnik V vaccine has been approved to tackle Covid-19 in 60 countries across the world. India is gonna import the vaccine and use it for emergencies. The efficacy of Sputnik V was determined to be 91.6% by The Lancet.
This week, the Therapeutic Goods Administration (TGA), Australia's medical regulator, has ruled that a 48-year-old woman's death due to blood clotting was a side effect of the AstraZeneca coronavirus vaccine.
Advertisement
Indian Doctor on Sputnik Vaccine Advisory Board
Russian Direct Investment Fund and the Gamaleya Centre initiated the creation of the international scientific advisory board on the Sputnik V vaccine, so that vaccine developers can exchange information, opinions and expertise with their leading foreign colleagues.
Russian Direct Investment Fund and the Gamaleya Centre initiated the creation of the international scientific advisory board on the Sputnik V vaccine, so that vaccine developers can exchange information, opinions and expertise with their leading foreign colleagues.
After Covishield and Covaxin, Sputnik V, developed by the Gamaleya National Research Institute of Epidemiology and Microbiology in Moscow, is now the third Covid-19 vaccine to get emergency use approval in India.
Advertisement
Dr.Reddy's Phase 3 Trial of Sputnik Vaccine Approved
Pharma major Dr.Reddy's Laboratories Ltd has received approval from the Drugs Control General of India (DCGI) to conduct Phase 3 clinical trial for the Sputnik V vaccine in India.
Pharma major Dr.Reddy's Laboratories Ltd has received approval from the Drugs Control General of India (DCGI) to conduct Phase 3 clinical trial for the Sputnik V vaccine in India.
Source-IANS
